Axim Biotechnologies Inc (AXIM) Total Assets by Year
Axim Biotechnologies Inc closed fiscal year 2023 with $4.1M in total assets, $11.8M in total liabilities and -$7.7M in shareholder equity. This represents a decrease of 2.1% from the prior fiscal year. The table below carries 13 fiscal years, from 2011 to 2023, and the quarters Axim Biotechnologies Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
AXIM Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.1M-2.1% | $4.2M-20.9% | $5.3M-52.9% | $11.3M+568.7% | $1.7M-19.0% | $2.1M-4.7% | $2.2M+51.3% | $1.4M+14.9% | $1.3M+70.8% | $738K+1199.6% | $57K-57.2% | $133K-3.3% | $137K |
| Total Liabilities | $11.8M+30.3% | $9.0M+18.0% | $7.7M-21.4% | $9.7M+15.3% | $8.5M+3.4% | $8.2M-3.6% | $8.5M+121.9% | $3.8M+29.2% | $3.0M+124.1% | $1.3M+775.1% | $151K+9.6% | $138K+8.2% | $127K |
| Total Equity | -$7.7M-58.7% | -$4.8M-106.4% | -$2.3M-249.3% | $1.6M+123.2% | -$6.8M-11.2% | -$6.1M+3.2% | -$6.3M-165.0% | -$2.4M-39.9% | -$1.7M-191.9% | -$581K-518.3% | -$94K-1899.1% | -$5K-146.0% | $10K |
AXIM Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2410-Q | Q1'2410-Q | Q4'2310-Q | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K | Q3'2110-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.7M-12.2% | $3.9M-2.7% | $4.1M-2.1% | $4.0M-9.7% | $4.2M-6.1% | $4.0M-20.2% | $4.2M-20.9% | $4.5M-68.6% | $4.5M-56.3% | $5.1M-55.1% | $5.3M-52.9% | $14.2M+17.5% |
| Total Liabilities | $13.3M-5.2% | $11.4M+11.6% | $11.8M+30.3% | $10.0M+12.9% | $14.0M+69.6% | $10.2M+20.2% | $9.0M+18.0% | $8.9M-7.7% | $8.3M-11.4% | $8.5M-11.9% | $7.7M-21.4% | $9.6M-2.5% |
| Total Equity | -$9.5M+2.2% | -$7.4M-20.9% | -$7.7M-58.7% | -$6.0M-35.9% | -$9.8M-161.2% | -$6.2M-80.0% | -$4.8M-106.4% | -$4.4M-194.2% | -$3.7M-459.8% | -$3.4M-310.2% | -$2.3M-249.3% | $4.6M+103.2% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Axim Biotechnologies Inc financials
Frequently Asked Questions
What was Axim Biotechnologies Inc's total assets in fiscal year 2023?
Axim Biotechnologies Inc closed fiscal year 2023 with $4.1M in total assets, $11.8M in total liabilities and -$7.7M in shareholder equity.
How fast is Axim Biotechnologies Inc's total assets growing?
Axim Biotechnologies Inc (AXIM) total assets fell by 2.1% year over year, from $4.2M to $4.1M in fiscal year 2023.
How has Axim Biotechnologies Inc's total assets changed over the years?
Across the 13 fiscal years this page covers, Axim Biotechnologies Inc (AXIM) total assets went from $137K in fiscal year 2011 to $4.1M in fiscal year 2023.
What was Axim Biotechnologies Inc's total assets in the most recent quarter?
Axim Biotechnologies Inc (AXIM) reported $3.7M in total assets in Q2 2024. This represents a decrease of 12.2% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Axim Biotechnologies Inc (AXIM) reported on that line in every period on record.